Protalix Biotherapeutics, Inc. (De)2024财年第三财季实现净利润3.24百万美元,同比增加275.14%

市场透视
23 Nov 2024

11月23日,Protalix Biotherapeutics, Inc. (De)(PLX.US)公布财报,公告显示公司2024财年第三财季净利润为3.24百万美元,同比增加275.14%;其中营业收入为17.96百万美元,同比增加73.53%,每股基本收益为0.04美元。从资产负债表来看,Protalix Biotherapeutics, Inc. (De)(PLX.US)总负债29.13...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10